Clinical Decision-Making About Neoadjuvant Nivolumab Plus Ipilimumab

被引：2
|
作者：
Gil-Sierra, Manuel David [1 ,2 ]
Sanchez-Hidalgo, Marina [1 ]
Alarcon de la Lastra-Romero, Catalina [1 ]
机构：
[1] Univ Seville, Fac Pharm, Dept Pharmacol, Calle Prof Garcia Gonzalez 2, Seville 41012, Spain
[2] Hosp Doctor Jose Molina Orosa, Dept Pharm, Arrecife, Spain
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 02期
关键词：
D O I：
10.1001/jamaoncol.2020.6989
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [1] Original Research Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
    Versluis, Judith M.
    Reijers, Irene L. M.
    Rozeman, Elisa A.
    Menzies, Alexander M.
    van Akkooi, Alexander C. J.
    Wouters, Michel W.
    Ch'ng, Sydney
    Saw, Robyn P. M.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Schilling, Bastian
    Long, Georgina, V
    Blank, Christian U.
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 51 - 57
  • [2] Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: a case report
    Reijers, I. L. M.
    Hilhorst, M.
    Tan, M.
    Klarenbeek, P. L.
    Hak, A. E.
    Blank, C. U.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : 1031 - 1032
  • [3] Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
    Chalabi, M.
    Fanchi, L. F.
    Van den Berg, J. G.
    Beets, G. L.
    Lopez-Yurda, M.
    Aalbers, A. G.
    Grootscholten, C.
    Snaebjornsson, P.
    Maas, M.
    Mertz, M.
    Nuijten, E.
    Kuiper, M.
    Kok, M.
    Van Leerdam, M. E.
    Schumacher, T. N.
    Voest, E. E.
    Haanen, J. B.
    ANNALS OF ONCOLOGY, 2018, 29 : 731 - 731
  • [4] Neoadjuvant Nivolumab plus /- Ipilimumab in Patients with Oral Cavity Cancer
    Schoenfeld, J. D.
    Hanna, G. J.
    Jo, V.
    Criscitiello, S.
    Rawal, B.
    Catalano, P. S.
    Chau, N.
    Lorch, J.
    Kass, J.
    Annino, D.
    Goguen, L.
    Ross, B.
    Margalit, D. N.
    Tishler, R. B.
    Uppaluri, R.
    Haddad, R. I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1114 - 1114
  • [5] Adjuvant Nivolumab or Ipilimumab plus Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant Nivolumab
    Khan, Tahsin M.
    Teke, Martha E.
    Karakousis, Giorgos C.
    Miura, John T.
    Brody, Robert M.
    Hernandez, Jonathan M.
    Mitchell, Tara C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2771 - 2772
  • [6] Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma
    Su, Y.
    Lin, Y.
    Hsiao, C.
    Ou, D.
    Chen, S.
    Wu, Y.
    Lee, W.
    Lin, J.
    Hsu, C.
    Ho, M.
    Lu, L.
    Wu, T.
    Lai, S.
    Chao, Y.
    Chou, T.
    Yen, C.
    Chen, L.
    Shan, Y.
    Cheng, A.
    Hsu, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S141 - S141
  • [7] Neoadjuvant ipilimumab-nivolumab superior to adjuvant nivolumab
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (08) : 566 - 566
  • [8] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Blank, Christian U.
    Rozeman, Elisa A.
    Fanchi, Lorenzo F.
    Sikorska, Karolina
    van de Wiel, Bart
    Kvistborg, Pia
    Krijgsman, Oscar
    van den Braber, Marlous
    Philips, Daisy
    Broeks, Annegien
    van Thienen, Johannes, V
    Mallo, Henk A.
    Adriaansz, Sandra
    ter Meulens, Sylvia
    Pronk, Loes M.
    Grijpink-Ongering, Lindsay G.
    Bruining, Annemarie
    Gittelman, Rachel M.
    Warren, Sarah
    van Tinteren, Harm
    Peeper, Daniel S.
    Haanen, John B. A. G.
    van Akkooi, Alexander C. J.
    Schumacher, Ton N.
    NATURE MEDICINE, 2018, 24 (11) : 1655 - +
  • [9] A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma
    Pothuri, Vikram
    Herndon, John
    Ballentine, Samuel J.
    Lim, Kian-Huat
    Fields, Ryan C.
    ONCOLOGIST, 2021, 26 (09): : 722 - 726
  • [10] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Christian U. Blank
    Elisa A. Rozeman
    Lorenzo F. Fanchi
    Karolina Sikorska
    Bart van de Wiel
    Pia Kvistborg
    Oscar Krijgsman
    Marlous van den Braber
    Daisy Philips
    Annegien Broeks
    Johannes V. van Thienen
    Henk A. Mallo
    Sandra Adriaansz
    Sylvia ter Meulen
    Loes M. Pronk
    Lindsay G. Grijpink-Ongering
    Annemarie Bruining
    Rachel M. Gittelman
    Sarah Warren
    Harm van Tinteren
    Daniel S. Peeper
    John B. A. G. Haanen
    Alexander C. J. van Akkooi
    Ton N. Schumacher
    Nature Medicine, 2018, 24 : 1655 - 1661
12345